CHMP issues positive opinion recommending DARZALEX® (daratumumab) for relapsed or refractory multiple myeloma

27th February 2017 Uncategorised 0

Genmab

More: CHMP issues positive opinion recommending DARZALEX® (daratumumab) for relapsed or refractory multiple myeloma
Source: MDlinx